Przejdź do zawartości
Merck

SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes.

The Journal of clinical investigation (2024-05-07)
Joan Sabadell-Basallote, Brenno Astiarraga, Carlos Castaño, Miriam Ejarque, Maria Repollés-de-Dalmau, Ivan Quesada, Jordi Blanco, Catalina Nuñez-Roa, M-Mar Rodríguez-Peña, Laia Martínez, Dario F De Jesus, Laura Marroqui, Ramon Bosch, Eduard Montanya, Francesc X Sureda, Andrea Tura, Andrea Mari, Rohit N Kulkarni, Joan Vendrell, Sonia Fernández-Veledo
ABSTRAKT

Pancreatic β-cell dysfunction is a key feature of type 2 diabetes, and novel regulators of insulin secretion are desirable. Here we report that the succinate receptor (SUCNR1) is expressed in β-cells and is up-regulated in hyperglycemic states in mice and humans. We found that succinate acts as a hormone-like metabolite and stimulates insulin secretion via a SUCNR1-Gq-PKC-dependent mechanism in human β-cells. Mice with β-cell-specific Sucnr1 deficiency exhibit impaired glucose tolerance and insulin secretion on a high-fat diet, indicating that SUCNR1 is essential for preserving insulin secretion in diet-induced insulin resistance. Patients with impaired glucose tolerance show an enhanced nutritional-related succinate response, which correlates with the potentiation of insulin secretion during intravenous glucose administration. These data demonstrate that the succinate/SUCNR1 axis is activated by high glucose and identify a GPCR-mediated amplifying pathway for insulin secretion relevant to the hyperinsulinemia of prediabetic states.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Anti-β-Actin antibody, Mouse monoclonal, clone AC-15, purified from hybridoma cell culture